Sign in
4

Changes in Ownership

Theriva Biologics, Inc. Filed Acc 0000890163-07-000161

Options or other derivatives

  • Director acquired 42,473 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Wolf Jeffrey Alan · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2007-02-27 Grant or award : show line 1 in the form Stock Options +42,473 75,000 D
Loading xslF345X02/s11-7152_ex.xml…